Day One Biopharmaceuticals, Inc. Common Stock (DAWN) Stock Price

DAWNStock

$0.00−42.34%52W

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta-1.29

DAWN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)191.57%

Price vs S&P 500 (4W)-12.03%

VGM Score63.42

Book Value / Share (Quarterly)$4.28

P/TBV (Annual)2.26x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.04

Price vs S&P 500 (YTD)126.31%

Gross Margin (TTM)89.12%

Net Profit Margin (TTM)-67.85%

EPS (TTM)$-1.04

10-Day Avg Trading Volume1.34M

EPS Excl Extra (TTM)$-1.04

EPS (Annual)$-1.04

ROI (Annual)-24.33%

Gross Margin (Annual)89.12%

Cash / Share (Quarterly)$4.28

Revenue Growth QoQ (YoY)83.92%

ROA (Last FY)-21.13%

EBITD / Share (TTM)$-1.23

ROE (5Y Avg)-40.27%

Operating Margin (TTM)-80.76%

Cash Flow / Share (Annual)$-1.04

P/B Ratio5.04x

P/B Ratio (Quarterly)2.17x

Net Income / Employee (Annual)$-602,900

EV / Revenue (TTM)12.82x

Net Interest Coverage (TTM)-0.46x

ROA (TTM)-20.69%

EPS Incl Extra (Annual)$-1.04

Current Ratio (Annual)8.02x

Quick Ratio (Quarterly)7.73x

3-Month Avg Trading Volume3.51M

52-Week Price Return-42.34%

Revenue / Employee (TTM)$888,700

Tangible BV / Share (Quarterly)$4.11

P/S Ratio (Annual)14.06x

Asset Turnover (Annual)0.31x

52-Week High$21.53

EPS Excl Extra (Annual)$-1.04

CapEx CAGR (5Y)111.62%

26-Week Price Return199.03%

Quick Ratio (Annual)7.73x

13-Week Price Return74.47%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.02x

Enterprise Value$2.03B

Asset Turnover (TTM)0.30x

Revenue / Employee (Annual)$888,700

Pretax Margin (Annual)-69.10%

Cash / Share (Annual)$4.28

3-Month Return Std Dev146.28%

Net Income / Employee (TTM)$-602,900

ROE (Last FY)-24.33%

Net Interest Coverage (Annual)-1.93x

EPS Basic Excl Extra (Annual)$-1.04

Receivables Turnover (TTM)7.79x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.04

ROI (TTM)-23.43%

P/S Ratio (TTM)14.06x

Revenue / Share (Annual)$1.53

Tangible BV / Share (Annual)$4.11

Price vs S&P 500 (52W)-49.07%

Year-to-Date Return131.01%

5-Day Price Return0.23%

EPS Normalized (Annual)$-1.04

ROA (5Y Avg)-37.47%

Net Profit Margin (Annual)-67.85%

Month-to-Date Return0.42%

Cash Flow / Share (TTM)$-2.29

EBITD / Share (Annual)$-1.23

Operating Margin (Annual)-80.76%

ROI (5Y Avg)-40.27%

EPS Basic Excl Extra (TTM)$-1.04

P/TBV (Quarterly)2.26x

P/B Ratio (Annual)2.17x

Inventory Turnover (TTM)3.57x

Pretax Margin (TTM)-69.10%

Book Value / Share (Annual)$4.28

Price vs S&P 500 (13W)70.85%

Beta-1.29x

Revenue / Share (TTM)$1.53

ROE (TTM)-23.43%

52-Week Low$6.90

vGradeD

gGradeA

mGradeB

vgmGradeB

DAWN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.62

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
DAWNDay One Biopharmaceuticals, Inc. Common Stock	D	A	B	14.1x	—	89.1%	—	$0.00
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Day One Biopharmaceuticals, Inc. Common Stock

Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company developing targeted therapies for genetically defined cancers, with initial focus on pediatric oncology, an underserved market with significant unmet medical needs. The company's lead candidate, DAY301, is an antibody-drug conjugate (ADC) that has demonstrated antitumor activity in preclinical studies.